Heron Therapeutics | HRTX - 自己資本および準備金

株価
0.85
毎日の変更
0.03 4.10%
毎月
-12.06%
毎年
-55.34%
Q2 予測
0.83




自己資本および準備金 変化する 日付
ALKERMES USD 1.82B 85.86M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 459.28M 387K 2025-12
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 693.11M 34.1M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Surmodics USD 111.31M 7.59M 2025-06
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Veracyte USD 1.26B 36.61M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12